Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials (original) (raw)

Diabetes Care: "Taking It to the Limit One More Time

Lyn Reynolds

Diabetes care, 2017

View PDFchevron_right

Evaluation of Guidelines on Diabetes Medication

Luca Monge

Annals of Internal Medicine, 2012

View PDFchevron_right

Antidiabetic Medications and Polypharmacy

Kelechi Ogbonna

Clinics in Geriatric Medicine, 2015

View PDFchevron_right

Oral Anti-diabetic Agents

Tahniyah Haq

Bangladesh Medical Journal, 2017

View PDFchevron_right

A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes

MIchael Polster

Journal of Medical Economics, 2010

View PDFchevron_right

Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride

Jaime E . Villena Chávez

Archives of Medical Research, 2006

View PDFchevron_right

Efficacy of Sitagliptin Versus Glimepiride 1-3 mg for Treatment of Type-2 Diabetes Patients

Praveen Yadav

International Journal of Pharmaceutical Investigation, 2020

View PDFchevron_right

Diabetes and Associated Complications in the South Asian Population

Alka Kanaya

Current Cardiology Reports, 2014

View PDFchevron_right

The Role of Diabetes Care and Its Contributions to the Field of Diabetes: A Profile in Progress

Lyn Reynolds

Diabetes Care, 2018

View PDFchevron_right

Guidelines for management of type 2 diabetes 2012: Common sense prevails!

Salem Beshyah

Ibnosina Journal of Medicine and Biomedical Sciences, 2012

View PDFchevron_right

Status of Diabetes Care: “It Just Doesn’t Get Any Better . . . or Does It?”

Lyn Reynolds

Diabetes Care, 2014

View PDFchevron_right

Treat-to-target trials in diabetes

Subhash Wangnoo

Indian Journal of Endocrinology and Metabolism, 2014

View PDFchevron_right

Type 2 diabetes quality of life patients treated with insulin and oral hypoglycemic medication

Andrzej Fal

Acta Diabetologica, 2011

View PDFchevron_right

Assessment of Safety and Efficacy of Bromocriptine in Comparison with Teneligliptin in Newly Diagnosed Type 2 Diabetes Mellitus

Tanuja Lella

Biomedical and Pharmacology Journal, 2020

View PDFchevron_right

Pathophysiology of diabetes mellitus complications: Metabolic events and control

paul chikezie

Biomedical Research and Therapy, 2021

View PDFchevron_right

Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)

Daniel Braga

European Journal of Clinical Pharmacology, 2011

View PDFchevron_right

The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

Hiba Ali

Metabolic Syndrome and Related Disorders, 2015

View PDFchevron_right

Status of Diabetes Care: New Challenges, New Concepts, New Measures—Focusing on the Future!

Lyn Reynolds

Diabetes Care, 2015

View PDFchevron_right

Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes

Tina Thethi

Annals of Internal Medicine, 2009

View PDFchevron_right

Diabetes mellitus: new therapeutic approaches to treat an old disease

Fernando H Lojudice

2009

View PDFchevron_right

Diabetes Mellitus: Too Many Controversies Affecting Care

Linda Hiebert

Journal of US-China Medical Science, 2013

View PDFchevron_right

Diabetes Intervention : Achieving Tight Glycemic Control Through Combination Therapy

Christopher Dezii

2001

View PDFchevron_right

Efeito do treinamento proprioceptivo em mulheres diabéticas

Elaine Guirro

Revista Brasileira de Fisioterapia, 2008

View PDFchevron_right

Scandinavian Society for the Study of Diabetes abstracts

Jørgen Lindgaard Pedersen

Diabetologia, 1966

View PDFchevron_right

A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes

E. Waclawski, Brian Frier

European Journal of Clinical Pharmacology, 1988

View PDFchevron_right